HDGF Inhibitors
HDGF Inhibitors encompass a group of small molecules that are designed to selectively target the Hepatoma-Derived Growth Factor (HDGF) protein's activity. HDGF is a nuclear protein that plays critical roles in various cellular processes, including cell growth, proliferation, and DNA repair. The inhibitors within this chemical class are designed to interact with specific binding sites or functional regions of the HDGF protein, effectively obstructing its normal function within the cell. By doing so, these inhibitors aim to modulate cellular pathways and biological processes that involve HDGF, leading to implications in cellular homeostasis and physiological functions.
Researchers and drug developers are actively investigating the structure and properties of HDGF inhibitors to gain insights into their mode of action and their ability as valuable research tools to study HDGF-related cellular functions. As research progresses, a deeper understanding of the molecular interactions between HDGF and its inhibitors is being achieved, driving the advancement of this chemical class and its applications in various scientific investigations.
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin, a widely used anticoagulant drug, has been reported to inhibit the binding of HDGF to its receptor on the cell surface, thereby disrupting downstream signaling pathways. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
A tyrosine kinase inhibitor targeting EGFR. By inhibiting EGFR, it could reduce downstream signaling pathways that may involve HDGF, leading to decreased HDGF activity. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a polyanionic compound that has been shown to inhibit the growth factor-binding activity of HDGF, thereby reducing its effects on cellular functions. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, which can alter gene expression profiles, including those involving HDGF, thereby potentially reducing HDGF activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A kinase inhibitor that targets multiple receptors including VEGFR and PDGFR. Its action could indirectly reduce HDGF activity by inhibiting pathways in which HDGF is involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor known to affect cell growth and proliferation, potentially influencing HDGF activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can affect various cellular processes, potentially leading to reduced HDGF activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound known to affect multiple signaling pathways, potentially influencing HDGF activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially reducing HDGF activity by influencing the PI3K/Akt pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could indirectly influence HDGF activity by altering signaling pathways where HDGF is involved. | ||||||